Monday, 20 January 2020

Korea News

  • INC Research expands in Korea to meet local demand

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2012

    Singapore: INC Research, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, opened a facility in South Korea to manage t...Read more

  • Taejoon eyes Korea top 10 list

    Korea |  Influencers | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

    Established in 1978, Taejoon Pharm has been a leading specialty pharma company in Korea in ophthalmology, contrast media and other sectors of the gastrointestinal area. Since 2002, the comp...Read more

  • Covidien gifts Korea a $21 mn medtech R&D center

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

    Singapore: Medical device developer, Covidien, has launched Covidien Center of Innovation Korea (CCI Korea), its first R&D, training and education center in Korea. With a total investme...Read more

  • BSA-CMR Survey: India, China lead in APAC CRO sector

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Yaskawa Electric invests in ReWalk exoskeleton

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2013

    Singapore: Israel-based ARGO Medical Technologies has partnered with innovative robotics experts Yaskawa Electric, Japan, as it continues the global expansion of its ReWalk exoskeleton devi...Read more

  • Korea FDA accepts IND application from Hanmi

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2012

    Singapore: Korean Food and Drug Administration (KFDA) has accepted Hanmi Pharmaceutical's investigational new drug application for KX-01, dual src/pretubulin inhibitor by Kinex Pharmaceuti...Read more

  • Japan gives patent for Medgenics IFNa pump

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

    Singapore: Medgenics received a Notice of Allowance from the Japanese Patent and Trademark Office for key claims protecting the use of Medgenics' Infradure Biopump technology for the deli...Read more

  • Japan, Korea lead in stem cell race

    Korea |  Opinion | By Nandita Singh | 0 Comment | 12 Nov, 2012

    In South Korea, two research teams led by Prof. Park Se-pill at Jeju National University Stem Cell Research Center and Mirae Biotech used non-viral vectors of nanoparticles and liposomal ma...Read more

  • NeuroMetrix, Handok join hands in Korea

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Singapore: NeuroMetrix and Handok Pharmaceuticals entered into an agreement according to which, Handok will be the exclusive distributor for NC-stat DPNCheck in the Republic of Korea. NC-s...Read more

  • Daewoong acquires Chinese firm for $16 mn

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: South Korea's leading pharmaceutical company, Daewoong Pharma has signed a deal to take over Liaoning Baifeng, a Chinese drug firm for $16 million. The South Korean company also...Read more

  • Radiotherapy leader sets up subsidiary in S. Korea

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 24 Aug, 2012

    Singapore: Varian Medical Systems, the world leader in radiotherapy and radiosurgery, is strengthening its leadership position in South Korea by establishing an in-country subsidiary. Varia...Read more

  • Kinex, Hanmi enroll patients for cancer trial

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Kinex Pharmaceuticals and Hanmi Pharmaceutical announced today that the first patient has been enrolled in Hanmi's phase Ib / IIa clinical trial in Korea. Kinex's dual Src/pretub...Read more

  • Quest signs $8 mn agreement with Korean parties

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Singapore: Canada-based Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cancer, has signed an investment agreement worth $8 million ...Read more

  • Samsung acquires US-based NeuroLogica

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Samsung Electronics America, a subsidiary of South Korean company Samsung Electronics, has acquired NeuroLogica, a computed tomography company headquartered in Danvers, Massachus...Read more

  • South Korea approves Halaven for breast cancer

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: Eisai's South Korean sales subsidiary has received approval from the regulatory authorities in South Korea to market the anticancer agent Halaven (eribulin mesylate) for the trea...Read more

  • LegoChem offers new platform in anti-cancer therapy

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2012

    Korea-based LegoChem Biosciences (LCB) was started in 2006 with the objective to accelerate discovery and development of new small molecule drugs. The company is committed to building susta...Read more

  • Medivir, Daewoong end hepatitis drug development

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

    Singapore: Sweden-based Medivir has discontinued the development of its hepatitis B compound MIV-210 based on a joint decision with Korea-based Daewoong Pharmaceutical. Under the terms of t...Read more

  • Agilent, Korea institute to launch neurometabolomics center

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 28 Oct, 2013

    Singapore: Agilent Technologies and Korea-based Daegu Gyeongbuk Institute of Science and Technology (DGIST) have collaborated to launch DGIST's new Neurometabolomics Excellence Research Cen...Read more



Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls